Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines-Reference-Cited by-同舟云学术

Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines

Published:2020-01 Issue: Volume:37 Page:101459
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Yamout B.^ORCID,Sahraian M.^ORCID,Bohlega S.,Al-Jumah M.,Goueider R.,Dahdaleh M.,Inshasi J.,Hashem S.,Alsharoqi I.,Khoury S.^ORCID,Alkhawajah M,Koussa S.,Al Khaburi J.,Almahdawi A.,Alsaadi T.^ORCID,Slassi E.,Daodi S,Zakaria M.^ORCID,Alroughani R.

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference182 articles.

1. Pregnancy outcomes in patients with active RRMS who received alemtuzumab in the clinical development program;Achiron;Mult. Scler. J.,2015

2. The prevalence of multiple sclerosis in the Middle East;Al-Hashel;Neuroepidemiology,2008

3. Rituximab versus fingolimod after natalizumab in multiple sclerosis patients;Alping;Ann. Neurol.,2016

4. Increasing prevalence and incidence rates of multiple sclerosis in Kuwait;Alroughani;Mult. Scler.,2014

5. JC virus seroprevalence and seroconversion in multiple sclerosis cohort: a Middle-Eastern study;Alroughani;J. Neurol. Sci.,2016

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY);Multiple Sclerosis and Related Disorders;2024-10

2. Differentiating multiple sclerosis and neuromyelitis optica spectrum disorders through pontine trigeminal nerve lesions: A comparative MRI study;European Journal of Radiology;2024-09

3. A future of AI-driven personalized care for people with multiple sclerosis;Frontiers in Immunology;2024-08-19

4. Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates;Multiple Sclerosis and Related Disorders;2024-08

5. Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment;Pharmaceuticals;2024-07-25